Evidence map›Paper›PMID 42563038›Full record

ArticleThe Journal of membrane biology2026

The Conserved Fusion Peptide Sequence of SARS-CoVs is Insensitive to Ca

Priyanka Mahapatra, Hirak Chakraborty

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of membrane biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Priyanka MahapatraSchool of Chemistry, Sambalpur University, Jyoti Vihar, Burla, Odisha, 768 019, India.
Hirak ChakrabortySchool of Chemistry, Sambalpur University, Jyoti Vihar, Burla, Odisha, 768 019, India. hirakchakraborty@gmail.com.ORCID https://orcid.org/0000-0001-7499-5707

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The viral envelope fuses with the host cell membrane to initiate viral infection. In the case of SARS-CoVs, the fusion process is catalyzed by the spike (S) protein. The S1 subunit interacts with the host cell receptor and assists in docking the viral particle at the cell surface, whereas the fusion process is induced by the insertion of a conserved hydrophobic motif at the N-terminal of the S2 subunit, known as a fusion peptide, into the host cell. Current experimental findings suggest that the fusion peptide of SARS-CoVs displays a strong Ca

Indexed as

CalciumPeptidesSevere acute respiratory syndrome-related coronavirusSpike Glycoprotein, CoronavirusViral Fusion ProteinsAmino Acid SequenceConserved SequenceMembrane FusionUnilamellar LiposomesVirus InternalizationCalciumPeptidesSpike Glycoprotein, CoronavirusUnilamellar LiposomesViral Fusion Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.